Drug comparisons
Saxagliptin vs Ertugliflozin
Saxagliptin (oral DPP-4 inhibitor) vs Ertugliflozin (oral SGLT2 inhibitor) for type 2 diabetes. Compare mechanisms, hypoglycemia, weight, CV benefits, and safety.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when selecting an oral add-on agent for type 2 diabetes between a DPP-4 inhibitor and an SGLT2 inhibitor.
Bottom line
Both lower blood sugar in type 2 diabetes but differ in class effects, so the better choice depends on patient comorbidities and risk factors.
All medication comparisons